Clinical

Can AI Spot Cancer Earlier? Where Imaging Helps and Where False Alarms Matter

In breast screening, AI support has been tested in a randomized trial of more than 100,000 women and a real-world study of 460,000. The results are promising, but false alarms, overdiagnosis and deskilling still matter.